It was reported that the increased level of leptin in obesity could promote BC initiation, progression, metastasis, and resistance to therapy through a variety of mechanisms including the activation of PI3K/Akt, JAK/AKT/STAT, and FAK-Src signaling pathway. Here, AKT1 is linked to obesity disorder.